Literature DB >> 12507502

Resistin release by human adipose tissue explants in primary culture.

John N Fain1, Paramjeet S Cheema, Suleiman W Bahouth, M Lloyd Hiler.   

Abstract

Resistin, also known as Fizz3 or ADSF, is a protein found in murine adipose tissue and inflammatory lung exudates. The present studies found that resistin was released by explants of human adipose tissue but the release was quite variable ranging from 3 to 158 ng/g over 48 h. The release of resistin was 250% greater by explants of omental than by explants of human subcutaneous abdominal adipose tissue. Resistin release by adipocytes was negligible as compared to that by the non-fat cells of adipose tissue. Leptin formation by adipocytes was 8-fold greater than its formation by the non-fat cells, while the formation of PAI-1 by adipocytes was 38% of that by the non-fat cells. The conversion of glucose to lactate as well as the formation of PGE(2) and IL-8 was approximately 15% of that by the non-fat cells. In contrast the release of IL-6 and IL-1beta by adipocytes was 4-7% of that by the non-fat cells while the formation of resistin and IL-10 by adipocytes was 2% of that by non-fat cells. The release of adiponectin by explants ranged from 1000 to 5000 ng/g over 48 h but did not correlate with that of resistin. The present data suggest that resistin release by explants of human adipose tissue in primary culture is largely derived from the non-fat cells present in the explants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507502     DOI: 10.1016/s0006-291x(02)02864-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  59 in total

Review 1.  Resistin: yet another adipokine tells us that men are not mice.

Authors:  P Arner
Journal:  Diabetologia       Date:  2005-11       Impact factor: 10.122

2.  Resistin confers resistance to doxorubicin-induced apoptosis in human breast cancer cells through autophagy induction.

Authors:  Zhenyu Liu; Aiping Shi; Dong Song; Bing Han; Zhiru Zhang; Le Ma; Dongxu Liu; Zhimin Fan
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 3.  Adipocyte-derived hormones, cytokines, and mediators.

Authors:  Cristina M Rondinone
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 4.  Human resistin: found in translation from mouse to man.

Authors:  Daniel R Schwartz; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2011-04-15       Impact factor: 12.015

5.  Association of ADIPOQ, leptin, LEPR, and resistin polymorphisms with obesity parameters in Hammam Sousse Sahloul Heart Study.

Authors:  Nesrine Zayani; Asma Omezzine; Imen Boumaiza; Ons Achour; Lamia Rebhi; Jihen Rejeb; Nabila Ben Rejeb; Ahmed Ben Abdelaziz; Ali Bouslama
Journal:  J Clin Lab Anal       Date:  2017-02-13       Impact factor: 2.352

6.  Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin.

Authors:  R Palanivel; A Maida; Y Liu; G Sweeney
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

7.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding.

Authors:  Stuart P Weisberg; Deborah Hunter; Reid Huber; Jacob Lemieux; Sarah Slaymaker; Kris Vaddi; Israel Charo; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2005-12-08       Impact factor: 14.808

8.  Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Québec Family Study.

Authors:  L Bouchard; S J Weisnagel; J C Engert; T J Hudson; C Bouchard; M C Vohl; L Pérusse
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

9.  Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells.

Authors:  Zhaofan Luo; Ying Zhang; Fangping Li; Juan He; Helin Ding; Li Yan; Hua Cheng
Journal:  Endocrine       Date:  2009-05-08       Impact factor: 3.633

10.  Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes.

Authors:  Chee W Chia; Olga D Carlson; Wook Kim; Yu-Kyong Shin; Cornelia P Charles; Hee Seung Kim; Denise L Melvin; Josephine M Egan
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.